Kounan, Japan

Hisaaki Uchida

This inventor holds 1 USPTO granted patent. Top assignee: Meito Sangyo Kabushiki Kaisha. Active years: 1986.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1986

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hisaaki Uchida: Innovator in Pharmaceutical Composition

Introduction

Hisaaki Uchida is a notable inventor based in Kounan, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the area of inhibiting platelet aggregation. His work has implications for various medical conditions, showcasing the importance of innovation in healthcare.

Latest Patents

Uchida holds a patent for a pharmaceutical composition that is effective in inhibiting platelet aggregation. The composition comprises guanosine monophosphate, which is represented by a specific formula. This formula includes a H₂PO₃ group and is designed to be used with a pharmaceutically acceptable salt and diluent or carrier. This innovation highlights Uchida's commitment to advancing medical treatments.

Career Highlights

Throughout his career, Hisaaki Uchida has been associated with Meito Sangyo Kabushiki Kaisha, where he has contributed to various research and development projects. His expertise in pharmaceutical compositions has positioned him as a valuable asset in the industry.

Collaborations

Uchida has worked alongside notable colleagues such as Kyoji Kito and Fumio Kuzuya. Their collaborative efforts have further enhanced the research and development of innovative pharmaceutical solutions.

Conclusion

Hisaaki Uchida's contributions to the field of pharmaceuticals, particularly through his patent for inhibiting platelet aggregation, demonstrate the vital role of inventors in advancing medical science. His work continues to inspire innovation in healthcare.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…